Posteri; Helena

Patent Applications and Registrations

Patent applications and USPTO patent grants for Posteri; Helena.The latest application filed is for "3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors".

Company Profile

0.20.13

Posteri; Helena - Travedona Monate N/A IT
Posteri; Helena - Travedona Monate (VA) IT
Posteri; Helena - Varese IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors Grant 9,073,893 - Papeo , et al. July 7, 2	2015-07-07
Isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors Grant 8,993,594 - Papeo , et al. March 31, 2	2015-03-31
Pyrazolo-quinazolines Grant 8,846,701 - Caldarelli , et al. September 30, 2	2014-09-30
3-oxo-2,3-dihydro-1h-indazole-4-carboxamide Derivatives As Parp-1 Inhibitors App 20140235675 - Papeo; Gianluca Mariano Enrico ; et al.	2014-08-21
3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibition Grant 8,765,972 - Papeo , et al. July 1, 2	2014-07-01
Isoquinolin-1(2h)-one Derivatives As Parp-1 Inhibitors App 20140045846 - Papeo; Gianluca Mariano Enrico ; et al.	2014-02-13
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors Grant 8,623,876 - Caruso , et al. January 7, 2	2014-01-07
Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors Grant 8,614,220 - Caruso , et al. December 24, 2	2013-12-24
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors Grant 8,598,172 - Caruso , et al. December 3, 2	2013-12-03
Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors Grant 8,592,416 - Papeo , et al. November 26, 2	2013-11-26
Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors Grant 8,426,417 - Caruso , et al. April 23, 2	2013-04-23
Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents Grant 8,309,578 - Mantegani , et al. November 13, 2	2012-11-13
Substituted Pyrrolo-pyrazole Derivatives As Kinase Inhibitors App 20120277248 - CARUSO; Michele ; et al.	2012-11-01
3-0x0-2,3-dihydro-1h-isoindole-4-carboxamides With Selective Parp-1 Inhibition App 20120245143 - Papeo; Gianluca Mariano Enrico ; et al.	2012-09-27
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors Grant 8,227,472 - Caruso , et al. July 24, 2	2012-07-24
Isoquinolin-1 (2h) -one Derivatives As Parp-1 Inhibitors App 20120157454 - Papeo; Gianluca Mariano Enrico ; et al.	2012-06-21
Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors App 20120122882 - Caruso; Michele ; et al.	2012-05-17
Bicyclic Pyrazole And Isoxazole Derivatives As Antitumor And Antineurodegenerative Agents App 20110294790 - Mantegani; Sergio ; et al.	2011-12-01
Pyrazolo--quinazolines App 20110105542 - Caldareli; Marina ; et al.	2011-05-05
Substituted Dihydropteridin-6-one Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors App 20110053944 - Caruso; Michele ; et al.	2011-03-03
Substituted Pyrazolo-quinazoline Derivatives, Process For Their Preparation And Their Use As Kinase Inhibitors App 20100216808 - Caruso; Michele ; et al.	2010-08-26
Substituted Pyrrolo-pyrazole Derivatives As Kinase Inhibitors App 20100010008 - Caruso; Michele ; et al.	2010-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.